Anti-tumour effects of perioperative ketamine in lung cancer: a non-randomised, exploratory biomarker study
Stephanie N Shishido1, Anya Shah1, Jeremy Mason2
1Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles CA, USA.
British Journal of Anaesthesia
|September 11, 2025
Abstract
No abstract available in PubMed .
Keywords:
biomarkerscirculating endothelial cells (CECs)circulating tumour cellsketamineliquid biopsynon-small cell lung cancer (NSCLC)More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.6K
06:40An In Vivo Mouse Model of Total Intravenous Anesthesia During Cancer Resection Surgery
Published on: June 8, 2021
2.9K
